Financials
Financial year 2024
M2 SURGERY from Rebecq, company number BE0730684370, closed financial year 2024 with a result of € 196,119 after tax. For that financial year M2 SURGERY recorded a gross margin of € 427,911 and equity of € 777,584. Compared with financial year 2023, the result moved from € 218,612 to € 196,119. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 777,584
▲ 33% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 196,119
▼ 10% vs 2023
Profit after tax over the fiscal year.
€ 397,738
▲ 30% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 3,332 paid out
2 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
€ 17,842
▼ 32% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 679,960
▼ 10% vs 2023
€ 73,368 is repaid this year. At this pace the long-term loan is gone in ≈ 9 years.
€ 5,807
▼ 62% vs 2023
Supplier invoices still open on the last day of the fiscal year.
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 103,637 | € 204,653 | € 345,566 | € 427,911 | ▲ 24% |
| Profit after taxes | € 70,251 | € 127,236 | € 218,612 | € 196,119 | ▼ 10% |
| Equity | € 240,638 | € 367,874 | € 584,820 | € 777,584 | ▲ 33% |
| Total debts | € 879,753 | € 859,646 | € 774,987 | € 726,086 | ▼ 6% |
| Cash | € 184,869 | € 253,803 | € 305,925 | € 397,738 | ▲ 30% |
| Land & buildings | € 881,638 | € 869,421 | € 852,990 | € 842,559 | ▼ 1% |
| Retained profit | € 236,638 | € 363,874 | € 580,820 | € 773,584 | ▲ 33% |
| Dividend | € 0 | € 0 | € 1,666 | € 3,332 | ▲ 100% |
| Bank debt | € 857,055 | € 789,969 | € 752,387 | € 679,960 | ▼ 10% |
| Balance sheet total | € 1,120,391 | € 1,227,521 | € 1,359,807 | € 1,530,270 | ▲ 13% |
Key figures of M2 SURGERY, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to M2 SURGERY?
What happened at M2 SURGERY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 196,119 (▼ 10% vs 2023). filed late Source: NBB ↗
- New establishment in Vorst. KBO
- Luciano MAZZEO CICCHETTI became a director. NBB
- Raquel LAMARTINE SABIDO MONTEIRO became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 70,251 profit in 2021 to € 196,119 profit in 2024.
Paid € 243,572 in corporate taxes since 2021.
Best year ever: 2023, with € 218,612 profit.
Paid out € 4,998 in dividends to the owners in total.
Management
Behind M2 SURGERY are Luciano MAZZEO CICCHETTI and Raquel LAMARTINE SABIDO MONTEIRO.
Directors
According to the 2024 annual accounts
Luciano MAZZEO CICCHETTI
Director
since 2019
Raquel LAMARTINE SABIDO MONTEIRO
Director
since 2019
Establishments
Establishment units
Physical locations of this company
Rue Duc d'Arenberg 71
1430 Rebecq
Alsembergse Steenweg 219 box 604
1190 Vorst
Active since 15 July 2019
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0730.684.370
- VAT number
- BE 0730.684.370
- Registered office
- Rue Duc d'Arenberg 71, 1430 Rebecq
- Names & denominations
- M2 SURGERY
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 15 July 2019
- Peppol
- Active · Active since 3 Dec 2025
- Activities · NACE
Activiteiten van huisartspraktijken
Activiteiten van medisch specialisten